MRUSMID

Merus N.V.

HealthcareBiotechnology
$90.00
$0.00(+0.00%)
52W$38.49
$97.14
Updated May 7, 12:00 AM
RSI15
RS Rating86/99
Beta0.32
Volatility70%
F-Score4/9
Mkt Cap$6.8B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Merus N.V. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is leading (RS Rating: 86), indicating clear outperformance against the broad market. Earnings growth of 14% provides fundamental context to the price action. However, RSI is deeply oversold at 15, suggesting potential for a mean-reversion bounce.

Relative Strength
86
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.32
vs S&P 500
LOW VOL
52W Position
88%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$95.43
50 SMA > 100 SMA$85.94
100 SMA > 150 SMA$76.75
150 SMA > 200 SMA$68.44

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$95.36-5.62%BELOW
50 SMA$95.43-5.69%BELOW
100 SMA$85.94+4.72%ABOVE
150 SMA$76.75+17.26%ABOVE
200 SMA$68.44+31.51%ABOVE

Price Performance

1D+0.0%
1W
1M
3M
6M-5.4%
YTD+0.0%
1Y+128.1%
3Y+65.1%
52-Week Trading Range88% from low
$90.00
52W Low$38.49
52W High$97.14

Technical Indicators

RSI (14)OVERSOLD
14.9
305070
VCP ScoreCOOL
5/10
Base depth: 11.1%

Risk Profile

Beta
0.32
52W Vol
70%
ATR
$
Max DD (1Y)
-16%

Volume Analysis

Today
50D Avg
Vol Ratio
x
Liquidity
MODERATE

Earnings Momentum

Q4'24+57%
$-0.45
Q1'25-137%
$-1.40
Q2'25-175%
$-2.23
Q3'25+14%
$-1.26
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+38.92%
5 Years:+4.68%
3 Years:-6.84%
TTM:+55.90%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-36.92%

Stock Price CAGR

10 Years:+24.52%
5 Years:+34.71%
3 Years:+65.12%
1 Year:+128.14%

Return on Equity

10Y Avg:-74.7%
5Y Avg:-43.9%
3Y Avg:-43.8%
Last Year:-50.6%

Key Metrics

Market Cap$6.8B
Gross Margin37.2%
Net Margin-6.0%
Piotroski F-Score4/9

Frequently Asked Questions

Is MRUS in an uptrend right now?

MRUS has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is MRUS overbought or oversold?

MRUS's RSI (14) is 15. The stock is oversold (RSI < 30), which could indicate a bounce opportunity.

Is MRUS outperforming the market?

MRUS has a Relative Strength (RS) Rating of 86 out of 99. Yes, MRUS is a market leader, outperforming 86% of all stocks over the past 12 months.

Where is MRUS in its 52-week range?

MRUS is trading at $90.00, which is 93% of its 52-week high ($97.14) and 88% above its 52-week low ($38.49).

How volatile is MRUS?

MRUS has a Beta of 0.32 and 52-week volatility of 70%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.